Correlation Between Reneo Pharmaceuticals and Sana Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Reneo Pharmaceuticals and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reneo Pharmaceuticals and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reneo Pharmaceuticals and Sana Biotechnology, you can compare the effects of market volatilities on Reneo Pharmaceuticals and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reneo Pharmaceuticals with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reneo Pharmaceuticals and Sana Biotechnology.

Diversification Opportunities for Reneo Pharmaceuticals and Sana Biotechnology

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Reneo and Sana is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Reneo Pharmaceuticals and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Reneo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reneo Pharmaceuticals are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Reneo Pharmaceuticals i.e., Reneo Pharmaceuticals and Sana Biotechnology go up and down completely randomly.

Pair Corralation between Reneo Pharmaceuticals and Sana Biotechnology

Given the investment horizon of 90 days Reneo Pharmaceuticals is expected to generate 0.61 times more return on investment than Sana Biotechnology. However, Reneo Pharmaceuticals is 1.64 times less risky than Sana Biotechnology. It trades about 0.36 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.24 per unit of risk. If you would invest  1,700  in Reneo Pharmaceuticals on September 30, 2024 and sell it today you would earn a total of  120.00  from holding Reneo Pharmaceuticals or generate 7.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy9.38%
ValuesDaily Returns

Reneo Pharmaceuticals  vs.  Sana Biotechnology

 Performance 
       Timeline  
Reneo Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Strong
Over the last 90 days Reneo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady technical indicators, Reneo Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Sana Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sana Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Reneo Pharmaceuticals and Sana Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Reneo Pharmaceuticals and Sana Biotechnology

The main advantage of trading using opposite Reneo Pharmaceuticals and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reneo Pharmaceuticals position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.
The idea behind Reneo Pharmaceuticals and Sana Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance